Education
About Us
Working with TipRanks
Follow Us
Sanofi (DE:SNW)
XETRA:SNW
SNW Analyst Ratings
Moderate Buy
10 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SNW Stock 12 Month Forecast
Average Price Target
€114.30
▲(25.44% Upside)
| Highest Price Target€124.06 | Average Price Target€114.30 | Lowest Price Target€91.31 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Exane BNP Paribas
Initiated
04/16/25
Leerink Partners
Reiterated
04/15/25
J.P. Morgan
Reiterated
04/15/25
Bank of America Securities
Reiterated
04/14/25
Jefferies
Reiterated
04/09/25
Deutsche Bank
Reiterated
04/07/25
Bernstein
Reiterated
04/03/25
Goldman Sachs
Initiated
03/21/25
Berenberg Bank
Reiterated
03/04/25
Barclays
€120→€125
Buy
37.18%
Upside
Reiterated
01/31/25
Sanofi (SAN:FP) (SNY) PT Raised to EUR125 at BarclaysBarclays analyst Emily Field raised the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR125.00 (from EUR120.00) while maintaining a Overweight rating.
Stifel Nicolaus
€123
Buy
34.99%
Upside
Reiterated
01/30/25
Sanofi's Strong Growth Prospects and Strategic Initiatives Justify Buy Rating
Kepler Capital
€92
Hold
0.97%
Upside
Reiterated
01/30/25
Kepler Capital Sticks to Its Hold Rating for Sanofi (SNYNF)
Guggenheim
€118→€125
Buy
37.18%
Upside
Reiterated
07/11/24
Sanofi price target raised to EUR 125 from EUR 118 at GuggenheimSanofi price target raised to EUR 125 from EUR 118 at Guggenheim
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Exane BNP Paribas
Initiated
04/16/25
Leerink Partners
Reiterated
04/15/25
J.P. Morgan
Reiterated
04/15/25
Bank of America Securities
Reiterated
04/14/25
Jefferies
Reiterated
04/09/25
Deutsche Bank
Reiterated
04/07/25
Bernstein
Reiterated
04/03/25
Goldman Sachs
Initiated
03/21/25
Berenberg Bank
Reiterated
03/04/25
Barclays
€120→€125
Buy
37.18%
Upside
Reiterated
01/31/25
Sanofi (SAN:FP) (SNY) PT Raised to EUR125 at BarclaysBarclays analyst Emily Field raised the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR125.00 (from EUR120.00) while maintaining a Overweight rating.
Stifel Nicolaus
€123
Buy
34.99%
Upside
Reiterated
01/30/25
Sanofi's Strong Growth Prospects and Strategic Initiatives Justify Buy Rating
Kepler Capital
€92
Hold
0.97%
Upside
Reiterated
01/30/25
Kepler Capital Sticks to Its Hold Rating for Sanofi (SNYNF)
Guggenheim
€118→€125
Buy
37.18%
Upside
Reiterated
07/11/24
Sanofi price target raised to EUR 125 from EUR 118 at GuggenheimSanofi price target raised to EUR 125 from EUR 118 at Guggenheim
Best Analysts Covering Sanofi
Which Analyst Should I Follow If I Want to Buy DE:SNW and Sell After:
1 Month
xxx
Success Rate
11/15 ratings generated profit
Average Return
+1.13%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 73.33% of your transactions generating a profit, with an average return of +1.13% per trade.
3 Months
xxx
Success Rate
15/23 ratings generated profit
Average Return
+2.88%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 65.22% of your transactions generating a profit, with an average return of +2.88% per trade.
1 Year
Success Rate
17/23 ratings generated profit
Average Return
+3.59%
reiterated a buy rating 10 days ago
Copying Graham Parry's trades and holding each position for 1 Year would result in 73.91% of your transactions generating a profit, with an average return of +3.59% per trade.
2 Years
xxx
Success Rate
17/23 ratings generated profit
Average Return
+5.19%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 73.91% of your transactions generating a profit, with an average return of +5.19% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SNW Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
0
0
0
0
0
Buy
15
16
20
20
16
Hold
8
7
8
10
7
Sell
5
2
2
0
0
Strong Sell
0
0
0
0
0
total
28
25
30
30
23
Each month's total comprises the sum of three months' worth of ratings.
SNW Financial Forecast
SNW Stock Forecast FAQ
What is DE:SNW’s average 12-month price target, according to analysts?
Based on analyst ratings, Sanofi’s 12-month average price target is 114.30.
What is DE:SNW’s upside potential, based on the analysts’ average price target?
Sanofi has 25.44% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sanofi a Buy, Sell or Hold?
Sanofi has a consensus rating of Moderate Buy, which is based on 10 buy ratings, 4 hold ratings and 0 sell ratings.
What is Sanofi’s share price target?
The average share price target for Sanofi is 114.30. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €124.06 ,and the lowest forecast is €91.31. The average share price target represents 25.44% Increase from the current price of €91.12.
The highest analyst share price target is €124.06 ,and the lowest forecast is €91.31. The average share price target represents 25.44% Increase from the current price of €91.12.
What do analysts say about Sanofi?
Sanofi’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of Sanofi?
To buy shares of DE:SNW, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.